Stay updated on Fisogatinib in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A dismissible notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” in response to an executive order.
    Difference
    1%
    Check dated 2026-10-25T16:53:26.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T22:27:02.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:26:44.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with an access-denied message. This indicates that core study information is not accessible on the page.
    Difference
    17%
    Check dated 2026-09-20T20:31:03.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    A funding attribution line '2015 ( U.S. NIH Grant/Contract )' was added to the study's records. The site revision tag was updated to 'Revision: v3.6.6' (replacing the previous 'v3.6.5').
    Difference
    0.1%
    Check dated 2026-08-30T17:36:45.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5 instead of v3.6.4, indicating a small site update reflected in the page footer/metadata.
    Difference
    0.0%
    Check dated 2026-08-09T12:25:56.000Z thumbnail image

Stay in the know with updates to Fisogatinib in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.